IAS 2019 – Social Media Toolkit

#IAS2019 Social Media Toolkit

Below, you will find social media content to be used to raise awareness of the need to prevent TB in order to end TB, especially among people living with HIV.

The content also includes information about a recent study showing that a short regimen for preventing TB (3HP) has been found safe when co-administered with a new first-line HIV Drug. The results pave the way for scale-up of TB preventive therapy across the 12 IMPAACT4TB countries, across three continents.

This content can be used across Twitter and Facebook ahead of and during the upcoming IAS Conference in HIV Science taking place in Mexico City from July 21-24 2019.

Use this social media toolkit to get involved in the conversation!

 

 

HASHTAGS

• #IAS2019
• #EndTB
• #StopTB

 

SAMPLE POSTS

Please Tweet and post to your Facebook, LinkedIn, Instagram and other relevant social networks. Also, share/retweet content from @AurumInstitute.

Suggested Tweets

• This week, we’ll be in Mexico City to talk about HIV and TB co-infection, and why prevention is the key to tackling the TB epidemic. Come and find us! #IAS2019 @GavinChurchyard http://bit.ly/2FRmY8l
• Over the past 40 years, an HIV diagnosis has gone from being a deadly disease to a chronic condition we can prevent & treat. But people living w/ HIV are now dying from TB in large numbers. Find out how to prevent this http://bit.ly/2LCrJGo #IAS2019
• A recent study confirmed that a new shorter regimen for preventing TB can be scaled up among people living with HIV, who are dying from TB in large numbers. Learn more: http://bit.ly/2LCrJGo #EndTB #IAS2019
• TB remains the world’s deadliest infectious disease. But a new study presented earlier this year offers new hope and paves the way for scale-up of shorter regimen for TB prevention among people living with HIV. http://bit.ly/2LCrJGo
• People living with HIV are at high risk of latent TB, but their infection goes unnoticed and untreated until it’s too late. It’s time to change the status quo and prevent TB to #EndTB #IAS2019
• In March this year, a new study showed that two game-changing regimens—one for preventing TB and one for treating HIV—can safely be co-administered. #EndTB #IAS2019 Find out more: http://bit.ly/2LCrJGo
• Our approach to preventing TB is failing, and we can and must do better. New research presented earlier this year offers hope of tackling the dual burden of latent TB infection and HIV, ultimately saving lives and making progress towards TB elimination. http://bit.ly/2LCrJGo
• If we really want to #endTB we need to tackle the hidden source of the problem–latent TB. It’s time to scale-up of TB prevention among people living with HIV, who are . #EndTB #IAS2019 Find out more: http://bit.ly/2LCrJGo
• TB is the leading cause of death among people living with HIV, causing one-third of all HIV deaths–around 400,000 people per year. But this doesn’t have to be the case. Tune into #IAS2019 on Saturday 20 July to find out more http://bit.ly/2FRmY8l @StopTB @PEPFAR

Suggested Facebook posts

• This week, we’ll be in Mexico City to talk about HIV and TB co-infection, and why prevention is the key to tackling the TB epidemic. Come and find us! #IAS2019 @GavinChurchyard http://bit.ly/2FRmY8l
• TB is the leading cause of death among people living with HIV, causing one-third of all HIV deaths–around 400,000 people per year. But this doesn’t have to be the case. Tune into #IAS2019 on Saturday 20 July to find out more http://bit.ly/2FRmY8
• 1.7 billion people (almost a quarter of the world) are infected with the bacteria that causes TB, and people living with HIV are at high risk of progressing from infection to TB disease. Yet it doesn’t have to be this way. It’s time to take action to shield people from this deadly disease. Find out more www.impaact4tb.org #IAS2019
• In an important moment for TB control, a new study recently found that a shorter regimen to prevent TB can be safely co-administered with dolutegravir—the first-line drug to treat HIV in many high-burden TB countries. This news paves the way for scale-up of this new regimen in 12 high-burden TB countries across three continents. Find out more: http://bit.ly/2LCrJGo
• Our approach to preventing TB is failing, and we can and must do better. Results presented earlier this year offer hope of tackling the dual burden of latent TB infection and HIV, ultimately saving lives and making progress towards TB elimination. Find out more: http://bit.ly/2LCrJGo
• If we really want to #endTB we need to tackle the hidden source of the problem–latent TB. A new study presented earlier this year paves the way for scale-up of TB prevention among people living with HIV. #IAS2019 Find out more: http://bit.ly/2LCrJGo
• People living with HIV are at high risk of latent TB, but their infection goes unnoticed and untreated until it’s too late. It’s time to change the status quo and prevent TB to #EndTB #IAS2019
• Over the past 40 years, an HIV diagnosis has gone from being the equivalent of a death sentence to becoming a chronic condition that we can prevent and treat. But people living with HIV are now dying from TB in large numbers – something we are here to change. Find out more http://bit.ly/2FRmY8l #IAS2019

Visual Assets

Video

• Video highlighting the problem of latent TB infection. Download here.
• Video highlighting the problem of latent TB infection + solution through 3HP. Download here.
• Videos are also available via YouTube here.

Shareable Images

Please use these with your social media posts – simply click on the image you want, right-click and download.